Sign in
Taking people in United StatesNo phase

Repeated mouth bacteria sampling to help detect Barrett's esophagus

Studies repeated mouth bacteria samples to spot Barrett's esophagus in adults.

Key facts

Who runs it
Columbia University
Where
Ann Arbor and New York, United StatesSee the 2 sites
Trial code
Registry title
Longitudinal Oral Microbiome Sampling for BE
Status
Recruiting
People taking part
275 people, planned
Started
19 Mar 2021
Expected to end
Aug 2027
Type of study
Observational, 2 groups
Treatments tested
  • Sample collection
Record updated
12 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have had or will have an upper endoscopy (a camera test of the food pipe and stomach). It includes people with Barrett's esophagus and people who never had it, to study saliva samples.

Age
18 years or older
Sex
All sexes
Disease stage
For Barrett's esophagus patients: the endoscopy shows Barrett's esophagus at least 1 cm (0.4 in) long (Prague classification: any C, M≥1), and biopsies show intestinal metaplasia. Control group: never diagnosed with Barrett's esophagus.
Earlier treatment
Must be scheduled for an upper endoscopy or have had one within the past three years. Barrett's patients cannot have had prior endoscopic therapy for Barrett's esophagus. Earlier endoscopic mucosal resection (EMR) of small spots is allowed if no ablation (tissue-destroying treatment) followed.

Main reasons for not taking part

  • History of head and neck cancer, esophageal squamous cell cancer or stomach cancer
  • Past surgery on the food pipe or stomach
  • Colonoscopy scheduled on the day of the first saliva sample
  • Only ERCP or endoscopic ultrasound (EUS) scheduled that day, without a standard upper endoscopy
  • Not able to give a saliva sample or give informed consent

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Scheduled for an upper endoscopy or had upper endoscopy within past three years
  • Eighteen years of age or older
  • Capable of producing a saliva sample
  • Able to give informed consent
  • For BE patients only: Endoscopic evidence of Barrett's esophagus (at least 1 cm maximal BE length; i.e. Prague classification: any C, M≥1), and intestinal metaplasia present on esophageal biopsies

Who cannot take part

  • For BE patients only: History of prior endoscopic therapy for BE except a history of prior Endoscopic mucosal resection (EMR) of focal lesions without subsequent ablative therapy is permitted
  • History of head and neck cancer or esophageal squamous cell or gastric cancer
  • History of esophageal or gastric surgery
  • Scheduled to undergo colonoscopy on the day of initial saliva collection
  • Scheduled only for Endoscopic retrograde cholangiopancreatography (ERCP) or Endoscopy ultrasound (EUS) without accompanying standard upper endoscopy on the day of initial saliva collection

Where in United States

  • University of MichiganAnn Arbor, United StatesContact: Joel H. Rubenstein, MDTaking people
  • Columbia University Irving Medical CenterNew York, United StatesContact: Julian Abrams, MDTaking people

About the trial

What the trial wants to find out

This is a longitudinal cohort study to assess the impact of repeated sampling of an oral microbiome signature for Barrett's esophagus (BE). Potential participants will be identified through chart review of patients who have had an endoscopy in the past three years.

The 2 groups in the trial

  • Control

    Patients who have undergone an endoscopy within the last three years and have never been diagnosed with Barrett's esophagus.

    Treatment: Sample collection

  • Barrett's Esophagus

    Patients who have undergone an endoscopy within the last three years and have histologically confirmed Barrett's esophagus. BE segment must be M\>1cm, and has not be treated with endoscopic eradication therapy (focal mucosal resection without subsequent eradication therapy is allowed).

    Treatment: Sample collection

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Repeated Sampling of the Oral Microbiome to Improve Detection of Barrett's Esophagus
Plain-language title
Repeated mouth bacteria sampling to help detect Barrett's esophagusGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
12 May 2026